1. South Korea Stocks

  2. •

    Consumer Cyclical

  3. •

    Apparel - Manufacturers
Wellbiotec Co., Ltd.

Wellbiotec Co., Ltd.

010600.KS
Wellbiotec Co., Ltd.KR flagKorea Exchange
11.00
KRW
-4.00
- -
1.00BMarket Cap

Total Valuation

Wellbiotec Co., Ltd. carries a market capitalization of 1.00B, placing it among publicly traded companies globally. Its enterprise value stands at 44.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.00B
Enterprise Value44.46B

Share Statistics

Wellbiotec Co., Ltd. currently has 90.92M shares outstanding.

Shares Outstanding90.92M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.60, and the price-to-book ratio stands at -0.35.

PE RatioN/A
PS Ratio0.60
PB Ratio-0.35
P/TBV Ratio2.95
P/FCF Ratio52.63
P/OCF Ratio110.60

Enterprise Valuation

On an enterprise value basis, Wellbiotec Co., Ltd. trades at an EV/EBITDA multiple of 0.00 and an EV/FCF ratio of 47.22. The EV/Sales ratio of 0.54 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.00 provides insight into valuation relative to core operating earnings.

EV / Sales0.54
EV / EBITDA0.00
EV / EBIT0.00
EV / FCF47.22

Financial Position

Wellbiotec Co., Ltd. maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

Current Ratio2.10
Quick Ratio0.71
Debt / Equity8.14
Debt / EBITDA-1.82
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-50.61
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2,454.87

Taxes

Income Tax353.69M
Effective Tax RateN/A

Stock Price Statistics

Wellbiotec Co., Ltd.'s stock has declined approximately -97.98165% over the past 52 weeks. The 50-day moving average sits at 471.30, while the 200-day moving average is 526.58.

Beta (5Y)N/A
52-Week Price Change-97.98165%
50-Day Moving Average471.30
200-Day Moving Average526.58
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Wellbiotec Co., Ltd. generated 82.88B in revenue and converted that into -18.77B in net income, yielding earnings per share of -184.38. EBITDA reached -776.33M, while operating income came in at -776.33M.

Revenue82.88B
Gross Profit10.26B
Operating Income-776.33M
Pretax Income-16.41B
Net Income-18.77B
EBITDA-776.33M
EBIT-776.33M
Earnings Per Share (EPS)-184.38

Balance Sheet

Wellbiotec Co., Ltd. holds 6.50B in cash and equivalents against 1.41B in total debt, resulting in a net debt position of -5.45B. Total book value stands at -142.70B, with working capital of 10.09B providing operational flexibility.

Cash & Cash Equivalents6.50B
Total Debt1.41B
Net Debt-5.45B
Equity (Book Value)-142.70B
Book Value Per Share-1,569.44
Working Capital10.09B

Cash Flow

Wellbiotec Co., Ltd. produced 448.02M in operating cash flow over the past twelve months. After subtracting -493.59M in capital expenditures, free cash flow totaled -45.57M - equivalent to -0.50 per share.

Operating Cash Flow448.02M
Capital Expenditures-493.59M
Free Cash Flow-45.57M
FCF Per Share-0.50

Margins

Wellbiotec Co., Ltd. operates with a gross margin of 12.38, reflecting its pricing power and cost economics. The operating margin of -0.94 and net profit margin of -22.64 provide insight into operational efficiency.

Gross Margin12.38
Operating Margin-0.94
Pretax Margin-19.80
Profit Margin-22.64
EBITDA Margin-0.94

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield3.29
FCF Yield1.90

Stock Splits

Wellbiotec Co., Ltd.'s most recent stock split took place on October 28, 2011 with a 10:1 split ratio.

Last Split Date10/28/2011
Split Ratio10:1

Scores

Wellbiotec Co., Ltd. posts an Altman Z-Score of -3.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.40